Stay Connected
Plugin created by StressFree Sites
-
Recent Posts
Recent Comments
- [BLOCKED BY STBV] Search and Social in Organ Donation Awareness | Christopher Taylor Barry, MD, PhD on Organ Donation: What Does it Take to Engender a Cultural Shift?
- [BLOCKED BY STBV] Dr. Barry’s Donate Life America Speech | Christopher Taylor Barry, MD, PhD on Linking Estate Planning with Organ Donation Registration
- [BLOCKED BY STBV] Deceased Donor Transplant Programs in India, Part 3: The Way Forward | Christopher Taylor Barry, MD, PhD on Deceased Donor Transplantation in India, Part 2: Indigenous Rackets and Transplant Tourism
- [BLOCKED BY STBV] Healthy Lifestyles for Healthy Organs | Christopher Taylor Barry, MD, PhD on Organ Donation Persuasive Speech: Dr. Chris Barry TEDx
- Healthy Lifestyles for Healthy Organs | Christopher Taylor Barry, MD, PhD on Deceased Donor Transplant Programs in India, Part 3: The Way Forward
Archives
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- February 2014
- January 2014
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- February 2013
- January 2013
- October 2012
- September 2012
- August 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- December 2011
- September 2011
- August 2011
- June 2011
- April 2011
- March 2011
Categories
Meta
Tag Archives: Dr. Christopher Barry
Participate in the Cycle of Life
The following is a speech I gave at the Greentopia Festival, Rochester, New York’s first green festival. But first, see this video testimonial from a woman volunteered to tell the story of her sister who received a liver transplant. She … Continue reading →
bLifeNY: The Challenges of Raising Organ Donation Awareness
The field of organ transplantation has become a victim of its own success. With vastly improved antirejection medications, surgical techniques, and medicines to prevent transplant related infections, the chances of long term success for all solid organ transplants are uniformly … Continue reading →
Protein Okay for Cirrhotics
I was just seeing a patient in liver transplant clinic today with end stage liver disease secondary to fatty liver disease leading to Non Alcoholic Steatohepatitis (NASH) and cirrhosis. She was miffed with her primary care physician because he had … Continue reading →
Fatty Liver Disease
The “Metabolic Syndrome”, defined by the International Diabetes Federation as the presence of central obesity (or increased waist circumference) plus any two of the four following conditions: insulin resistance, high blood levels of triglycerides (fat), low levels of HDL (High … Continue reading →
A Conversation About Kidney Transplantation
Here is a typical conversation that I have with a potential kidney transplant recipient. Dr. Barry: Good morning. Your Nephrologist has referred you to our center for evaluation of your kidney transplant surgical candidacy. I understand that the cause of … Continue reading →
Surgery in the Cirrhotic Patient
For this particular article, I am focusing on general surgical procedures such as hernia repair, gall bladder removal, and liver cancer resection in patients with cirrhosis. This information is applicable to other types of surgery, such as cardiac, colon, breast, … Continue reading →
Liver and Kidney Transplantation in People with HIV
Transplanting people with HIV infection for end stage organ disease was, not too long ago, considered inappropriate because of the unknown long term outcomes and the fear that administering antirejection drugs to patients with a preexisting immunosuppressive viral infection would … Continue reading →
Why Biopsy Liver Cancer?
Liver cancers, especially when early in their genesis, are usually asymptomatic. Often they are detected when an ultrasound scan, a CT scan or MRI are performed for other reasons, or when a patient has underlying liver disease (cirrhosis of any … Continue reading →
Posted in liver cancer treatment, scholarship
|
Tagged Dr. Christopher Barry, genomics, laparoscopic liver surgery, liver biopsy, liver cancer, liver cancer genomics, liver disease, liver transplantation, liver tumor ablation, micro RNA, personalized medicine, RFA.IRE, sorafenib, TACE, University of Rochester Medical Center
|
1 Comment